Dai Yujia,Wang Le,Mcdaniel Keith,Hasvold Lisa,Marjanovic Jasmina,Mcclellan William,Sheppard George,Liu Dachun,Fidanze Steven D.,Holms James H.
申请号：
NZ63106214
公开号：
NZ631062A
申请日:
2014.06.27
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
The disclosure relates to compounds of formula (I) wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
